These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1719416)

  • 1. A Plasmodium falciparum malaria vaccine candidate which contains epitopes from the circumsporozoite protein and a blood stage antigen, 5.1.
    Caspers P; Etlinger H; Matile H; Pink JR; Stüber D; Takács B
    Mol Biochem Parasitol; 1991 Aug; 47(2):143-50. PubMed ID: 1719416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66.
    Millet P; Campbell GH; Sulzer AJ; Grady KK; Pohl J; Aikawa M; Collins WE
    Am J Trop Med Hyg; 1993 Mar; 48(3):424-31. PubMed ID: 7682382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Production and molecular characterization of Plasmodium falciparum recombinant circumsporozoite protein with 37 NANP and 4 NVDP epitopes].
    Uyar Y; Akşit A; Karaca S; Ceylan ŞS; Yürük M
    Mikrobiyol Bul; 2017 Jan; 51(1):41-51. PubMed ID: 28283009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.
    Yang C; Collins WE; Xiao L; Saekhou AM; Reed RC; Nelson CO; Hunter RL; Jue DL; Fang S; Wohlhueter RM; Udhayakumar V; Lal AA
    Vaccine; 1997 Mar; 15(4):377-86. PubMed ID: 9141208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I clinical trial of a recombinant malaria vaccine consisting of the circumsporozoite repeat region of Plasmodium falciparum coupled to hepatitis B surface antigen.
    Vreden SG; Verhave JP; Oettinger T; Sauerwein RW; Meuwissen JH
    Am J Trop Med Hyg; 1991 Nov; 45(5):533-8. PubMed ID: 1835311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).
    Udhayakumar V; Saekhou A; Fang S; Jue D; Wohlhueter RM; Lal AA
    Vaccine; 1998; 16(9-10):982-8. PubMed ID: 9682348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide.
    Pessi A; Valmori D; Migliorini P; Tougne C; Bianchi E; Lambert PH; Corradin G; Del Giudice G
    Eur J Immunol; 1991 Sep; 21(9):2273-6. PubMed ID: 1889465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses.
    Khan F; Porter M; Schwenk R; DeBot M; Saudan P; Dutta S
    PLoS One; 2015; 10(11):e0142035. PubMed ID: 26571021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice.
    Del Giudice G; Cheng Q; Mazier D; Berbiguier N; Cooper JA; Engers HD; Chizzolini C; Verdini AS; Bonelli F; Pessi A
    Immunology; 1988 Feb; 63(2):187-91. PubMed ID: 2450833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies.
    Triller G; Scally SW; Costa G; Pissarev M; Kreschel C; Bosch A; Marois E; Sack BK; Murugan R; Salman AM; Janse CJ; Khan SM; Kappe SHI; Adegnika AA; Mordmüller B; Levashina EA; Julien JP; Wardemann H
    Immunity; 2017 Dec; 47(6):1197-1209.e10. PubMed ID: 29195810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of opsonizing antibodies after injection of recombinant Plasmodium falciparum vaccine candidate antigens in preimmune Saimiri sciureus monkeys.
    Perraut R; Mercereau-Puijalon O; Mattei D; Bourreau E; Garraud O; Bonnemains B; Pereia de Silva L; Michel JC
    Infect Immun; 1995 Feb; 63(2):554-62. PubMed ID: 7822021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
    Enders B; Hundt E; Knapp B
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
    Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
    Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitopes of the human malaria parasite P. falciparum carried on the surface of HBsAg particles elicit an immune response against the parasite.
    von Brunn A; Früh K; Müller HM; Zentgraf HW; Bujard H
    Vaccine; 1991 Jul; 9(7):477-84. PubMed ID: 1716808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum.
    Rodriguez R; Moreno A; Guzman F; Calvo M; Patarroyo ME
    Am J Trop Med Hyg; 1990 Oct; 43(4):339-54. PubMed ID: 2240362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells.
    Herrington DA; Losonsky GA; Smith G; Volvovitz F; Cochran M; Jackson K; Hoffman SL; Gordon DM; Levine MM; Edelman R
    Vaccine; 1992; 10(12):841-6. PubMed ID: 1455910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary and secondary responses to (NANP) peptides by Plasmodium falciparum sporozoites in various strains of mice.
    Del Giudice G; Cheng Q; Mazier D; Meuwissen JH; Grau GE; Corradin G; Pessi A; Verdini AS; Lambert PH
    Scand J Immunol; 1989 May; 29(5):555-62. PubMed ID: 2471257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a synthetic malaria vaccine: cyclization of a peptide eliminates the production of parasite-unreactive antibody.
    Etlinger HM; Trzeciak A
    Philos Trans R Soc Lond B Biol Sci; 1993 Apr; 340(1291):69-72. PubMed ID: 8099745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses to a synthetic peptide-based malaria vaccine candidate: influence of sequence variants of the peptide.
    Etlinger HM; Renia L; Matile H; Manneberg M; Mazier D; Trzeciak A; Gillessen D
    Eur J Immunol; 1991 Jun; 21(6):1505-11. PubMed ID: 2044658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.